These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 18780866)
21. Micronutrient supplementation for patients with metastatic cancer. Stark JJ; Anderson GT; Birdsall TC; Nixon D; Zang E; Haase GM Nutr Cancer; 2000; 38(2):296-8. PubMed ID: 11525609 [No Abstract] [Full Text] [Related]
22. Do antioxidants interfere with radiation therapy for cancer? Moss RW Integr Cancer Ther; 2007 Sep; 6(3):281-92. PubMed ID: 17761641 [TBL] [Abstract][Full Text] [Related]
23. Use of antioxidant supplements during breast cancer treatment: a comprehensive review. Greenlee H; Hershman DL; Jacobson JS Breast Cancer Res Treat; 2009 Jun; 115(3):437-52. PubMed ID: 18839308 [TBL] [Abstract][Full Text] [Related]
24. Why have antioxidants failed in clinical trials? Steinhubl SR Am J Cardiol; 2008 May; 101(10A):14D-19D. PubMed ID: 18474268 [TBL] [Abstract][Full Text] [Related]
25. The phase III candidate: can we improve the science of selection? Bajorin D J Clin Oncol; 2004 Jan; 22(2):211-3. PubMed ID: 14665614 [No Abstract] [Full Text] [Related]
26. Response surface methodology and the design of clinical trials for the evaluation of cancer chemotherapy. Carter WH Cancer Treat Rep; 1985 Oct; 69(10):1049-53. PubMed ID: 4042084 [No Abstract] [Full Text] [Related]
27. Design issues in dose-finding Phase I trials for combinations of two agents. Fan SK; Venook AP; Lu Y J Biopharm Stat; 2009; 19(3):509-23. PubMed ID: 19384692 [TBL] [Abstract][Full Text] [Related]
28. International Clinical Trials in Radiation Oncology. Large field trials. Rubin P; Heilmann HP Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S65-76. PubMed ID: 3292484 [No Abstract] [Full Text] [Related]
30. Dietary supplement use in cancer care: help or harm. Hardy ML Hematol Oncol Clin North Am; 2008 Aug; 22(4):581-617, vii. PubMed ID: 18638690 [TBL] [Abstract][Full Text] [Related]
31. Antioxidants and chemotherapy. Galland L Altern Ther Health Med; 2007; 13(5):13. PubMed ID: 17900036 [No Abstract] [Full Text] [Related]
32. Lipid replacement therapy: a nutraceutical approach for reducing cancer-associated fatigue and the adverse effects of cancer therapy while restoring mitochondrial function. Nicolson GL Cancer Metastasis Rev; 2010 Sep; 29(3):543-52. PubMed ID: 20717704 [TBL] [Abstract][Full Text] [Related]
33. Factorial designs for randomized clinical trials. Byar DP; Piantadosi S Cancer Treat Rep; 1985 Oct; 69(10):1055-63. PubMed ID: 4042085 [No Abstract] [Full Text] [Related]
34. Drug targeting in cancer therapy: the magic bullet, what next? Duncan R; Connors TA; Meada H J Drug Target; 1996; 3(5):317-9. PubMed ID: 8866651 [No Abstract] [Full Text] [Related]
35. Antioxidant supplements and their risk of skin cancers. Ezzedine K; Hercberg S; Malvy D Clin Dermatol; 2010; 28(6):695-6. PubMed ID: 21034993 [No Abstract] [Full Text] [Related]
36. Is there a role for supplemented antioxidants in the prevention of atherosclerosis? Katsiki N; Manes C Clin Nutr; 2009 Feb; 28(1):3-9. PubMed ID: 19042058 [TBL] [Abstract][Full Text] [Related]
37. Modelling chemotherapy resistance in palliation and failed cure. Monro HC; Gaffney EA J Theor Biol; 2009 Mar; 257(2):292-302. PubMed ID: 19135065 [TBL] [Abstract][Full Text] [Related]
38. Study suggests antioxidants inhibit exercise-induced insulin sensitivity. Head KA Altern Med Rev; 2009 Jun; 14(2):99-102. PubMed ID: 19594220 [No Abstract] [Full Text] [Related]
39. An efficient design for phase III studies of combination chemotherapies. Ellenberg SS; Eisenberger MA Cancer Treat Rep; 1985 Oct; 69(10):1147-54. PubMed ID: 4042093 [No Abstract] [Full Text] [Related]
40. Does physical exercise modify antioxidant requirements? Margaritis I; Rousseau AS Nutr Res Rev; 2008 Jun; 21(1):3-12. PubMed ID: 19079851 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]